Cantor Fitzgerald Biotech Analyst Watsek, along with CEO Valliant, President & CBO Rawat and CFO Crowley discuss industry trends of radiopharmaceuticals on a conference call on December 5 at 1 pm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FUSN:
- Fusion expands pact with BWX Technologies to strengthen actinium supply
- BWX Technologies and Fusion Pharmaceuticals partner in actinium-225 production
- Fusion Pharmaceuticals reports Q3 EPS (25c), consensus (40c)
- Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates
- Oppenheimer reiterates Outperform rating on Fusion after ESMO abstract release
